The Spring 2021 Edition of the AGA Clinician’s Companion—the go-to resource for busy clinicians who can’t afford to spend hours sifting through research to find clinical value—is available!
The AGA Clinician’s Companion summarizes high-impact findings recently published in the AGA journals Gastroenterology and Clinical Gastroenterology and Hepatology (CGH). An annual subscription provides access to the current edition as well as past issues.
Articles in the Spring 2021 Edition cover the effects of diet-modulated autologous fecal microbiota transplantation on weight regain, factors associated with the success of biofeedback for fecal incontinence, and the lack of association betwen famotidine use and 30-day mortality in patients hospitalized with COVID-19. It also includes summaries of the efficacy of long-term treatment with a monoclonal antibody against IL13 in patients with eosinophilic esophagitis (EoE), and the efficacy of tofacitinib in treatment of patients with immune checkpoint inhibitor-associated colitis.
Other articles cover clinical response and remission rates between patients with Crohn’s disease receiving vs not receiving corticosteroids during anti-TNF induction therapy, and a systematic review and meta-analysis comparing the effectiveness of entecavir and tenofovir disoproxil fumarate in prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. One Clinician’s Companion article summarizes the observation of hyperlipasemia in almost 12% of COVID-19 patients with mild to moderate pancreatic injury, and another article discusses changes in the epidemiology and diagnosis of celiac disease.
Features of the AGA Clinician’s Companion include:
- Curated articles from Gastroenterology and CGH.
- Clinical practice take-home points identify the clinical utility of cutting-edge research.
- Easily accessible whether you’re in the clinic, at home or on the go.
- Articles organized by topic.
- PDF format requires no internet connection.